CD7 Drives AML Chemoresistance, Europe Sees ADHD Surge, Scientists Tune Chirality with Structured Beams, HKU Med Pilot Boosts Health, and more...
Science News DailyShow Notes
CD7 Protein Identified as Key Driver of Chemoresistance in AML, Redefining Treatment Approaches
ADHD Diagnoses Surge in Europe: Improved Awareness Drives Recognition, Not Epidemic
Revolutionary Light Control: Scientists Tune Chirality and Spin with Structured Beams
HKUMed's Chronic Disease Co-Care Pilot Exceeds Targets, Boosts Health Outcomes in Hong Kong
Neutron Star Collision Creates Ghostly 'Gold Factory' in Milky Way
To subscribe visit https://www.brief.news. For more updates in your inbox each morning visit www.brief.news.
Image credit: BIOENGINEER.ORG
More from Science News Daily
(0:10): World's Lightest Wireless Microscope "Airscope" Revolutionizes Neural Imaging in Freely Moving Animals
(0:10): Disc Medicine's Bitopertin Shines in Phase 3 EPP Trial, Paving Way for FDA Submission
(0:10): UTA Study Aims to Slash Radiation in Cardiac CT Scans with AI-Powered Reconstruction
(0:10): Breakthrough Study Maps Alzheimer's Impact on Brain Cells at Single-Cell Resolution
(0:10): Breakthrough High-Entropy Oxide Film Promises Ultra-Efficient Electronics and Data Storage